UNIQUE BIOCONJUGATION PLATFORM

BrickBio's platform technology enables custom tailoring of any protein with homogenous, site-specific and site-selective modifications for research and therapeutic applications and enables novel classes of biologics, including multi-site bispecific antibodies. 

PROTEIN ENGINEERING​

Improve protein characteristics, such as increasing serum half-life, improved specificity, or boosted activity

BIOCONJUGATION KITS

​

RUO kits are available for a variety of applications: dye-linked, oligo-linked,

and immuno-based assays

PHARMA PARTNERSHIPS​

​

Development of custom protein-based therapeutics or research assays to drastically improve R&D productivity

ANTIBODY CONJUGATION

Empowering the next generation of ADCs with improved efficacy, dosage, and modification homogeneity

THERAPEUTIC PIPELINE

We are currently developing early-stage biologic therapeutic candidates with improved characteristics​

IN VIVO CELL BASED ASSAYS

Investigation of protein half-life or protein-protein interactions in vivo with high temporal control 

RECENT NEWS

OUR TEAM

JOHN BOYCE

CEO, Co-Founder,

TIGER GENE

JAMES ITALIA, PhD

VP, COMMERCIAL

DEVELOPMENT

ABHISHEK CHATTERJEE, PhD

SENIOR ADVISOR &

CHAIRMAN OF SAB

AUDREY WARNER

HEAD OF BUSINESS DEVELOPMENT

BACK TO TOP